HTRA1 gene therapy (Disc Medicine/StrideBio)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHTRA1 gene therapy (Disc Medicine/StrideBio)
Drug Alias Nameadeno-associated viral vector delivered antibody therapy (Disc Medicine)AAV delivered antibody (Disc Medicine)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionSerine protease HTRA1 stimulants
TargetsSerine protease HTRA1
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDisc Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStridebio IncDisc Medicine Inc
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A